AEBP1 and neoplasm: By integrating single-cell RNA-sequencing (scRNA-seq) data from multiple cancer types and performing functional assays using three-dimensional (3D) spheroids of CAFs, we sought to clarify whether AEBP1/ACLP serves as a stromal determinant that enhances tumor stiffness and contributes to immune exclusion within the tumor microenvironment.